
Virginia Hernández-Gea
Médico Hepatólogo, HCBResearch group
- Regulation of liver microcirculation in cirrhosis and hepatic vascular diseases Accredited researcher (R3A)
Featured publications
-
The Endothelium as a Driver of Liver Fibrosis and Regeneration
Authors:Reference: Cells 2020. -
Precision medicine in variceal bleeding: Are we there yet?
Authors:Reference: Journal Of Hepatology 2020. -
Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy
Authors:Reference: Hepatology 2020. -
The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery
Authors:Reference: Journal Of Hepatology 2019. -
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs.
Authors:Reference: Journal Of Hepatology 2019. -
Porto-sinusoidal vascular disease: proposal and description of a novel entity
Authors:Reference: Lancet Gastroenterology & Hepatology 2019. -
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis
Authors:Reference: Liver International 2019. -
Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer
Authors:Reference: Clinical And Translational Gastroenterology 2019. -
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis.
Authors:Reference: Liver International 2019. -
TIPS Indications and Contraindications—Pushing the Limits: Is Earlier Better?
Authors:Reference: Curr Hepatol Rep 2019.
Featured Projects
-
Precision medicine in portal vein thrombosis: identification of new therapeutic targets and development of a unique theranostic approach
Principal investigator: Virginia Hernandez GeaFunder: Ministerio de Ciencia e InnovaciónCode: PI20/0056Duration: 01/01/2021 - 31/12/2023 -
La autofagia endotelial gobierna la respuesta de la célula hepática estrellada al daño hepático: regeneración o fibrosis? Análisis del secretoma endotelial para el desarrollo de nuevos tratamientos antibibroticos
Principal investigator: Virginia Hernandez GeaFunder: Instituto de Salud Carlos IIICode: PI17/00398Duration: 01/01/2018 - 31/12/2020 -
Role of liver endothelial cell dysfunction and its epigenetic regulation in the natural history of NAFLD.
Principal investigator: Virginia Hernandez GeaFunder: CIBEReHDCode: EHD18PI01/2018Duration: 01/01/2018 - 31/12/2019 -
Acción CIBER en enfermedad hepàtica por virus de la hepatitis C. Impacto del tratamiento con Nuevos antivirales en la historia natural de la cirrosis por el virus de la hepatitis C, identificación de factores predictives de no respuesta.
Duration: 01/01/2017 -
Clinical Study of BreathID LF System to train the algorithm for the 13C-Methacetin Breath test (MBT) in assessment of Portal Hypertension in Patients with Compensated Liver Cirrhosis.EXALENZ BIOSCIENCE LTD
Duration: 01/07/2016